4-(3-Methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid

CAS: 60875-16-3

Ref. 3D-FM44543

Información del producto

• Nombre: 4-(3-Methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid
• Sinónimos: 1-(4-Carboxyphenyl)-3-methyl-2-pyrazolin-5-on, 1-(4-Carboxyphenyl)-3-methyl-2-pyrazolin-5-one, 1-(4-Carboxyphenyl)-3-methyl-2-pyrazolinone, 1-(4-Carboxyphenyl)-3-methyl-5-pyrazolone, 1-(p-Carboxyphenyl)-3-methyl-5-pyrazolone, 4-(3-Methyl-5-oxopyrazol-1-yl)benzoic acid, 4-(3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoate, 4-(3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid, 4-(4,5-Dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid, Benzoic acid, 4-(4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)-, Benzoic acid, p-(3-methyl-5-oxo-2-pyrazolin-1-yl)-, Maquindox

Descripción

4-(3-Methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid (PMBA) is a chromatographic and spectroscopic reagent that is used in the analysis of glycosidic bonds. PMBA has been shown to be effective in preventing the formation of advanced glycation end products, which are substances that can cause diabetes. PMBA has also been found to have a protective effect on the kidneys and liver and may prevent damage to cells in these organs. This drug has been tested for pharmacological effects and toxicity in healthy subjects, type 2 diabetic patients, and diabetic patients.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 218.21 g/mol
• Fórmula: C₁₁H₁₀N₂O₃
• Pureza: Min. 95%
• InChI: InChI=1S/C11H10N2O3/c1-7-6-10(14)13(12-7)9-4-2-8(3-5-9)11(15)16/h2-5H,6H2,1H3,(H,15,16)
• Clave InChI: InChIKey=CUGBBQWDGCXWNB-UHFFFAOYSA-N
• SMILES: CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1